biotech
biotech Articles
Alder Bio shares skyrocketed on Monday after the firm announced that Lundbeck would be acquiring it. The transaction is valued at up to $1.95 billion and is expected to close in the fourth quarter of...
Published:
Last Updated:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Published:
Last Updated:
Ardelyx shares dropped on Friday after the firm announced that the FDA has approved its treatment of irritable bowel syndrome with constipation in adults.
Published:
Last Updated:
Adverum Bio shares dropped sharply on Thursday after the firm announced data from its Optic Phase 1 clinical trial in wet age-related macular degeneration.
Published:
Last Updated:
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Last Updated:
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
Published:
Last Updated:
Xeris Pharmaceuticals shares were halted briefly on Tuesday after the firm announced that it has received regulatory approval from the FDA for Gvoke, its treatment of severe hypoglycemia in pediatric...
Published:
Last Updated:
Intra-Cellular Therapies shares dipped on Tuesday after the firm released a disappointing update from the FDA concerning its treatment for schizophrenia.
Published:
Last Updated:
Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in...
Published:
Last Updated:
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Published:
Last Updated:
Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in...
Published:
Last Updated:
NextCure appears to be one of those companies that has flown under the radar of the investing community since its initial public offering in 2019.
Published:
Last Updated:
While just announced huge deal seems to be the big break that Cidara Therapeutics needs, one analyst believes this stock could nearly double in the next 12 months.
Published:
Last Updated:
GBT shares jumped on Thursday after the company announced that the FDA has accepted for filing the company’s New Drug Application for voxelotor as a treatment of sickle cell disease.
Published:
Last Updated:
Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off from this FDA sugar high.
Published:
Last Updated: